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Abstract
High-affinity nicotinic receptors containing beta2 subunits (β2*) are widely expressed in the brain, 
modulating many neuronal processes and contributing to neuropathologies such as Alzheimer’s 
disease, Parkinson’s disease and epilepsy. Mutations in both the α4 and β2 subunits are associated 
with a rare partial epilepsy, autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE). Here 
we introduced one such human missense mutation into the mouse genome to generate a knock-in 
strain carrying a valine-to-leucine mutation β2V287L.β2V287L mice were viable and born at an 
expected Mendelian ratio. Surprisingly, mice did not display an overt seizure phenotype; however 
homozygous mice did display significant alterations in their activity-rest patterns. This was 
manifest as an increase in activity during the light cycle suggestive of disturbances in the normal 
sleep patterns of mice; a parallel phenotype to that found in human ADNFLE patients. Consistent 
with the role of nicotinic receptors in reward pathways, we found that β2V287L mice did not 
develop a normal proclivity to voluntary wheel running, a model for natural reward. Anxiety-
related behaviors were also affected by the V287L mutation. Mutant mice spent more time in the 
open arms on the elevated plus maze (EPM) suggesting that they had reduced levels of anxiety. 
Together, these findings emphasize several important roles of β2* nicotinic receptors in complex 
biological processes including the activity-rest cycle, natural reward, and anxiety.
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Introduction
Neuronal nicotinic acetylcholine receptors (nAChRs) belong to a super family of Cys-loop 
ligand-gated ion channels whose members also include receptors for GABA, glycine and 
5HT (1). Most nAChRs are pentameric heteromers which can be assembled from the known 
11 mammalian subunits α2-10 and β2-4 leading to considerable functional heterogeneity (2). 
The majority of neuronal receptors are comprised of the α4 and β2 subunits (3, 4) and are 
widely expressed throughout the CNS (5). In particular the high-affinity β2-containing 
receptors (β2*) are ubiquitous in the brain (6) and their important neuromodulatory role has 
implicated them in several cognitive processes and pathophysiological conditions (7). 
Generation of a β2 knockout mouse greatly enhanced our understanding of β2* receptor 
function in vivo. These studies demonstrated that β2* receptors were necessary for all 
neuronal high-affinity nicotine binding sites in the CNS (8). Both the physiological effects 
on cellular excitability, and the behavioral effects of reinforcement by nicotine were 
abolished in knockout mice, demonstrating that β2 subunits are requisite members of 
functional receptors (9). Subsequent studies in β2 knockout mice have further uncovered 
several important phenotypes including an important role of β2* receptors in associative 
learning (8), locomotor activity (10, 11), exploration (12) and sleep (13, 14).
Recently, genetic association studies have linked the α2, α4 and the β2 subunit to autosomal 
dominant nocturnal frontal lobe epilepsy (ADNFLE). In one family a single missense 
mutation in the gene encoding the β2 receptor, CHRNB2, leads to a valine to leucine 
substitution at position 287 (V287L), a residue which sits in the second transmembrane 
domain of the receptor subunit and contributes to receptor gating (15). Examination of the 
impact of the V287L in recombinant receptors has revealed several effects of this mutation 
on β2* receptor function; slowed channel desensitization (15), an increase in the apparent 
affinity of agonists (16), a decrease in Ca2+-dependent potentiation (17), and effects on 
channel assembly and trafficking (18). ADNFLE can occur in patients who are heterozygous 
for the missense mutation; however penetrance is incomplete, with only a proportion of 
carriers affected by seizures. While the genetic basis for these familial epilepsies have been 
uncovered, the environmental contribution to the disease, and the cellular and behavioral 
aspects are not as clear.
In the present study, we generated a novel mutant mouse harboring the human ADNFLE 
mutation in the Chrnb2 gene (β2V287L). This knock-in strain is potentially a valuable asset 
for examining the cellular mechanisms of the disease. In addition, given the widespread 
expression and high-affinity agonist binding toβ2* receptors in the brain, β2V287L mice can 
be used for further determining the role of β2* receptors in vivo by analyzing the 
endophenotypes generated by this “gain-of-function” mutation. We found that spontaneous 
motor seizures occurred only rarely in β2V287L mutant mice, however a more robust 
phenotype was a disequilibrium in activity-rest patterns in this strain. β2V287L mice were 
more active during the light cycle, suggesting that normal sleep patterns are disturbed. 
Consistent with a role for β2* receptors in reward pathways we also found that β2V287L mice 
had deficits in the development of voluntary wheel running. In addition, mutant mice 
displayed a reduction in anxiety-related behaviors. Taken together our findings demonstrate 
several important roles of β2* receptors and indicate that development of β2V287L mice 
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provides a more concise view of the cellular and molecular basis for ADNFLE and the 
related phenotypes of the β2V287L missense mutation.
Materials and Methods
Generation of β2V287L mice
Conventional gene-targeting techniques were used to generate β2V287L knock-in mice (see 
supplementary Figure S1). A 20 kb genomic DNA fragment containing the Chrnb2 gene 
was isolated from a bacterial artificial chromosome (BAC) clone (RPCI-271-H24, obtained 
from BACPAC Resource Center at Children’s Hospital Oakland Research Institute in 
Oakland). A cassette containing a neomycin resistance (neo) gene, flanked by loxP sites, 
under the control of the phosphoglycerol kinase (PGK) promoter was introduced into the 
intron 720 bp downstream of exon 5 (Figure S1a). R1 mouse embryonic stem cells (19) 
were electroporated with the linearized targeting construct, maintained in G418 for positive 
selection, and screened by Southern blot for homologous recombination (Figure S1b). 
Chimeric animals produced by injection of these cells into C57BL/6 blastocysts were bred 
with C57BL/6 mice, and germ-line transmission of the mutation confirmed by Southern blot 
analysis of genomic DNA (Figure S1c). The neo cassette was removed in mice by crossing 
with a “Cre-deleter” line which expressed Cre recombinase in all tissues under the control of 
the protamine 1 promoter (20). Cre-mediated germline deletion of the neo cassette was 
confirmed by Southern blot and PCR genotyping. Mice heterozygous for the targeted allele 
were backcrossed greater than ten generations onto a C57BL/6 background. All wt and hom 
mutant mice used in these experiments were littermates derived from het crosses. Same sex 
littermates were housed 2–5 per cage, and maintained at 22°C, with a 12hr light/dark cycle.
Rotarod test
Motor coordination and balance were tested on an accelerating rotarod. Mice were placed on 
the rotarod and the speed accelerated at a rate of 0.1 rpm/s starting from 5 rpm. Mice were 
subjected to 3 trials per day for 3 consecutive days with ~30 minutes of inter-trial interval.
Wheel-running experiments
Wheel-running experiments were performed using the Wheel System (Lafayette 
Instruments) in a testing room with a 12-hr light, 12-hr dark light-dark (LD) cycle. In total 
experiments lasted for 37 days. 24-hr patterns of wheel-running activity were recorded and 
analyzed with ClockLab software (Coulbourn Instruments).
Open-field experiments
Open-field tests were performed in 42 cm × 42 cm behavioral chambers (Medical 
Associates). Movement was detected by infrared beam breaks. Animals were housed in a 
12-hr:12-hr LD cycle prior to testing. The room for the open-field test had the same 12-hr:
12-hr LD cycle. For experiments in Figure 4A–D, mice were introduced to chambers 3 hrs 
before lights were switched off. Their activity in the chamber was monitored for 28 hr. Food 
and water was provided in the testing chamber. Different cohorts of mice were used in the 
experiments in Figure 4E–F. The tests were conducted during the light cycle, ~3 hrs before 
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dark onset. Each mouse was placed in the chamber for 30 minutes each day for 5 
consecutive days.
Anxiety-related behaviors
The elevated plus maze (EPM) test was performed using a maze consisting of two open 
arms (30 × 5 cm) and two closed arms (30 × 5 cm) constructed of black Plexiglas that 
extended from a center platform. The closed arms had sides of clear Plexiglas (15 cm tall, 
0.5 cm thick). The entire apparatus was mounted 33 cm above the surface of the floor. Tests 
were performed during the dark phase of the LD cycle (~ 2 to 5 hrs after dark onset). Each 
test was begun by placing the mouse in the center of the maze facing one of the open arms. 
Each mouse was allowed to stay on the EPM for 5 minutes, and data was acquired by video 
tape. Subjects were scored for the total amount of time spent, and the number of entries into 
the open and closed arms, determined by placement of all four paws into that area. For open-
field anxiety tests mice were placed in the center of a behavioral chamber (42 cm × 42 cm) 
and allowed to explore the whole field for 30 mins. Time spent in the inner squares, which is 
defined as a 30 × 30 cm central area that covers ~52% of open-field area, and inner-square 
crossings were used as a measure of anxiety-related behavior. Tests were performed during 
the light phase of the LD cycle (~3 hrs before the dark onset). L/D exploration tests were 
performed in the same behavioral chambers during the dark phase of the LD cycle (~ 2 to 5 
hrs after dark onset). An L/D insert was used which divided the chamber into two 
compartments; one relatively large and bright, and the other small and dark. Mice were 
initially placed in the lit side, and transitions between the two sides and the time spent in 
each compartment were recorded for 5 min.
Nicotine-Induced seizures
Prior to experiments, mice were housed under a 12:12-hr L/D cycle. Mice were subjected to 
intraperitoneal injections with vehicle (phosphate buffer), or various doses of nicotine (n ≥ 5 
for each group). Animals received a single i.p. injection and were observed for the ensuing 
5–10 min for seizure activity and scored for their overall sensitivity to nicotine on a scale of 
1 to 7. Seizure classification was based on previously published systems with slight 
modifications (21, 22). Class 0: no visible response. Class 1: sedation and loss of 
locomotion. Class 2: circling, head bobbing, Straub tail (with tail bending > 60° angle, 
lasting > 10s), fast breathing, slight back hunch, head bending. Class 3: loss of balance 
(wobbling), slight tremors, moderate back hunch. Class 4: severe tremors, severe back 
hunch, very slight convulsion, body jerking, tail swing, forelimb clonus. Class 5: wild 
running, clonic body movement, falling with clonic forelimb and hindlimb movement. Class 
6: clonic-tonic convulsion (both limbs), falling with tonic movement. Class 7: tonic 
hyperextension of the hindlimb, death.
Morris Water Maze
Experiments were conducted as previously described (23). Briefly a 120 cm diameter tank 
filled with opaque water and containing a transparent platform submerged 1cm below the 
surface was used in combination with an automated video tracking system to record the 
swim path, velocity and time taken to reach the platform (latency) or the time spent in each 
zone. Mice were first trained to find a visible platform for 3 days (3 trials per day). Hidden 
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platform training was conducted one day after the completion of the visible platform 
training. Mice were trained for 6 days (3 trials per day) to find the submerged platform at a 
fixed position. Distal cues in the testing room were provided as spatial references. Each trial 
lasted either until the mouse found the platform, or for 60s. Starting points were changed 
every trial. Mice were allowed to rest on the platform for 15s after each trial. For the reverse 
test, the hidden platform was moved to the opposite quadrant without changing any distal 
visual cues. Mice were then trained to find this new platform location for 3 days.
Statistical analysis
Statistical analyses were conducted with Graphpad Prism. Data of all three genotypes, wt, 
het and hom, were analyzed. One-way ANOVA was used when genotype was the only 
grouping variable, and when data were collected in a single trial or single session. 
Differences between two means were assessed with Tukey’s multiple-comparison tests, 
unless specified otherwise. Student’s t-test was used to assess significance between 2 groups 
in Figure 4D. For the multiple trial experiments, two-way RM ANOVA was conducted to 
assess the effects of both genotype and sessions/trials. Genotype comparisons at individual 
time points/trials were assessed by Bonferroni post-tests. One-way RM ANOVA was 
conducted to assess the effects of training blocks/trials within the same genotype group. 
Post-test for linear trend was carried out to determine whether there is an increasing/
deceasing trend during habituation tests (Figure 4F). All data are presented as mean ± SEM. 
Differences were considered significant if p values were < 0.05.
Results
Using standard gene-targeting techniques we introduced the V287L mutation into the mouse 
Chrnb2 gene (Figure S1). Mutant β2V287L mice were born at the expected Mendelian ratio, 
suggesting that there was little, if any, problem with embryo development, or even any 
negative impact of the mutation on perinatal survival. Spontaneous motor seizures rarely 
occurred in the mutant mice. However when mice were followed for longer periods, we 
found that homozygous mice (hom) had a significantly more pronounced mortality rate 
(Figure S1 F & G). It is possible that an undetected seizure endophenotype contributed this 
increased mortality (24), or alternatively, as high affinity nAChRs are known to be 
important to respiratory patterns (25), alterations in breathing and arousal responses during 
sleep, could contribute to increased death in these animals.
Activity-rest patterns are altered in β2 V287L mice
In the human disease, ADNFLE seizures occur predominantly during sleep (26). Even in the 
absence of seizures, many ADNFLE patients endure severe sleep disruption and excessive 
daytime fatigue (27, 28). These clinical observations suggest that ADNFLE mutations may 
affect activity-rest rhythms. We tested this idea in animals using wheel-running experiments 
by following animals continuously for 37 days (n=10 for each group). In the first set of 
experiments we analyzed wheel-running using actograms created during the final 10 days, 
once mice had become habituated to the wheel apparatus (Figure 1). We found that the 
activity-rest profile in hom mice was significantly altered compared to wt animals. Wt 
animals exhibited typical activity consolidation during the dark cycle. Their activity onset 
Xu et al. Page 5
Mol Psychiatry. Author manuscript; available in PMC 2012 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
was coincident with the onset of the dark cycle and activity peaked to the maximal activity 
levels early in the dark period (Figure 1Ai and Bi). However, in hom mutant mice the 
individual activity-rest cycles were less consolidated into the dark cycle as indicated by a 
high level of fragmentation during both dark and light periods (Figure 1Aiii). The activity of 
wt animals peaked 3–5 hrs into the dark cycle, and then gradually declined to low levels 
during the remainder of the dark period, with much reduced activity present at the onset of 
the light cycle (Figure 1Bi). The het group had an activity profile similar to wt mice but with 
some subtle differences such as elevated activity at the end of the dark cycle. In contrast, 
β2V287L hom mutant mice had a grossly different activity pattern. Hom mice did not have a 
rapid transition to high activity with the onset of the dark cycle, the latency to peak activity 
during the dark cycle was lengthened, and activity remained elevated at the end of the dark 
cycle and beginning of the light phase (Figure 1Biii).
A closer examination of the individual activity bouts more acutely revealed disturbances of 
activity-rest consolidation in β2V287L mutant mice. During the light cycle, wt mice exhibited 
few activity bouts (1.3 ± 0.2) which were of short average duration (15.4 ± 1.4 min) (Figure 
2A & B). During the dark phase of the cycle, wt mice had an increase in the number of 
activity bouts which were consolidated into longer episodes of sustained activity (133 ± 7.5 
min). In contrast mutant hom mice performed significantly more activity bouts both during 
the light (2.3 ± 0.3; F2, 27 = 3.56 p= 0.043) and dark cycle (6.1 ± 0.6; F 2,27 = 5.30, p= 
0.012) compared to wt mice (Figure 2A & B). The duration of these activity bouts was not 
different during the light cycle (wt: 15.4 ± 1.4 min; hom: 19.0 ± 1.0 min, F 2,523 = 2.57, p > 
0.05). However the average duration of bouts during the dark cycle was significantly 
reduced in hom mice (70 ± 4.7 min, F 2,1428 = 32.98, p< 0.0001) compared to wt animals. 
The increased number of activity bouts during the light phase is indicative of frequent sleep 
interruptions in the β2V287L mutant mice. In addition, the increase in the number of activity 
bouts of relatively shorter duration during the dark phase suggest that β2V287L rest more 
frequently during the dark cycle, and are unable to maintain consolidated individual activity 
episodes for the same duration as wt and het mice.
When we calculated the activity of mice by measuring the total number of wheel turns we 
found that hom mutants exhibited ~40% of the running activity as compared to wt mice 
(F2,27=11.15, p=0.0002) (Figure 2C). This overall decrease in activity was primarily due to a 
significant decline in number of wheel turns during the dark phase (Figure 2D, F2,27=12.61, 
p<0.0001) with no effect of genotype observed on the total wheel turns during the light 
cycle (wt: 414 ± 110; hom: 496 ± 219, F2,27 =0.73, p>0.05). Therefore only 1.8 ± 0.4 % of 
the total activity of wildtype mice was during the light cycle, whereas a significantly higher 
portion of the activity of β2V287L was in the same period (6.6 ± 1.7 %, F2, 27 = 3.434, p = 
0.047) (Figure 2E).
Development of wheel-running activity as a natural reward
The initial aim of the wheel-running experiments was to determine activity-rest patterns in 
β2V287L mice. However time-course analysis of daily wheel-running activities revealed a 
surprising effect of the mutation on the development of voluntary wheel-running (Figure 
3A). Animals were allowed free access to wheels and experiments were conducted during a 
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12:12-hr LD cycle for a total of 37 days. After wheels were introduced to the home cage, wt 
mice increased their daily running activity over the first 12 days. After this initial elevation 
running activity was maintained at a near plateau state for the remainder of the 37 day 
period, similar to what has been reported previously for voluntary running behavior (29)
(Figure 3A). Het mice showed a similar pattern in running behavior, with a steady increase 
in daily running that peaked at day 17, 5 days later than wt mice. Running activity was 
subsequently maintained close to this maximum peak activity (Figure 3A). In contrast, hom 
mice performed considerably less wheel-running than their het and wt littermate controls 
throughout the duration of the test. While there was an initial increase of activity lasting for 
approximately 6 days, hom mice never reached the high activity of the wt and het mice. 
Analysis of the running activities during the first 20 days revealed a significant gene-dosage 
effects (F2,513=7.66, p=0.0023) and genotype-day interaction (F38,513=3.42, p<0.0001). 
During the last 10 days of the test when the running activities of all three cohorts were stable 
(F18,243=0.85, p=0.65, for genotype-day interaction), the gene-dosage effect of the β2V287L 
mutation on daily running was significant (main genotype effect: F2,243=12.25, p=0.0002)
(Figure 3A). The development of voluntary wheel running by rodents, as measured by the 
increase of total wheel running by day, has been established as a model for natural reward 
(29, 30). Therefore, it is possible that that the β2V287L mutation in vivo affects reward 
pathways, consistent with the known involvement of β2* receptors in other reward and 
addiction processes (31). In order to rule out the possibility that the reduced running in 
mutant mice was instead caused by a general motor deficit, we conducted rotarod tests to 
examine if motor coordination/balance and motor learning were altered in β2V287L mutant 
mice (Figure 3B). Trials were performed over three consecutive days (3 trials/day) and the 
daily averages for the latency to fall from the accelerating rotarod were measured. Each 
cohort (wt, n= 23; het, n= 25; hom, n=19) showed improvement in their ability to remain on 
the rotarod across days (F2,128 = 61.2; p< 0.0001); however hom mutants outperformed het 
and wt groups on each day of testing. Overall the hom mutant mice were able to remain on 
the rotarod significantly longer during the test than wt and het mice (main effect of 
genotype, F2,128=7.46, p=0.0012). There was no difference in the body weights of wt, het, or 
hom mice, eliminating the possibility that size or weight differences could contribute to the 
ability of mice to remain on the rotarod (Figure 3C). Therefore, surprisingly motor 
coordination and learning was actually improved by the β2V287L hom mutation, and the 
significant reduction in voluntary wheel-running in hom mutant mice is unlikely to be 
caused by a general motor deficit.
Open-field activity and locomotor habituation in β2V287L mice
In the experiments just described, activity-rest patterns were monitored by wheel-running 
activity of mice in a well-habituated environment. In order to further assess locomotor 
activity and daily activity-rest rhythms, we performed open-field tests. Naïve animals (wt, 
n=14; het, n=15; hom, n =13) were introduced to activity chambers at 09:00 hr (Zeitgeber 
time, 3 hrs before light-off) and were monitored until 13:00 hr on the second day. Mice of 
all three genotype groups exhibited activity-rest patterns that are consistent with normal 
daily circadian rhythms. Activity of all mouse cohorts was consolidated during the dark 
phase, and the onset of increased activity was coincident with the dark onset time. All three 
groups reached the maximal level of activity 3 – 4 hrs after dark onset, and subsequently 
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activity gradually declined for all three groups (Figure 4A)(het data not shown). About 8 hrs 
into the dark phase, wt (and het) mice displayed an abrupt reduction in activity level, which 
then remained low until the final hour of the dark phase (Figure 4A). In contrast, hom 
mutant mice maintained their activity levels during the same time period. All mouse cohorts 
demonstrated a brief increase in activity around light-onset, followed by very low levels of 
activity during the entire light-phase. Overall, there was no significant difference in the total 
distance run by wt and hom mice (Figure 4B). However, the difference in distance traveled 
by hom and het mice did achieve significance (F2,29= 4.80, P = 0.0137) (Figure 4b). This 
small increase in overall activity over the 28 hour period is due to the sustained activity of 
hom mice during the last six hours in the dark phase (Figure 4A white box). There was no 
difference in the activity between any of the genotypes in this open field test during the 12-h 
light phase (Distance traveled; wt: 37000 ± 4300 cm; het: 31000 ± 2800 cm; hom: 38000 ± 
3100 cm, F2,39 =1.23, p=0.30). This is in contrast to the increased activity of hom mice that 
we observed during the light phase in the well-habituated environment (Figure 1).
The same experiment also allowed us to determine the initial exploratory locomotor activity 
of β2V287L mice by measuring the distance traveled during the first 90 minutes of the open 
field test. Hom mutant mice demonstrated increased levels of activity, travelling over the 
greatest distance in this novel environment (overall effect of genotype: F2,39 =2.64 P=0.08; 
wt vs. hom, p=0.030, t-test) (Figure 4C & D). Over the course of the experiment each mouse 
cohort habituated to the novel environment, with activity declining over time; however, hom 
mutant mice habituated significantly more slowly (Figure 4C) (F8,156=2.12, p=0.037 for 
time-genotype interaction). Taken together, these results suggest that that intra-session 
habituation to a novel environment is partially impaired in hom β2V287L mutant mice.
The above results suggest that β2V287L have a more robust exploratory response in a novel 
environment. To test this further we performed further test on different cohorts of mice in 
the open field chamber. In this case, mice were introduced to the open field for only 30 
minutes each day for 5 consecutive days to test inter-session habituation. Both locomotion 
(horizontal distance traveled) and rearing (vertical counts measured by beam breaks) were 
quantified. The distance traveled on Day 1 of the experiment was the same for each 
genotype group (Figure 4E). However, on the Day 2 trial het and wt mice exhibited a large 
decline in locomotion whereas hom mice exploratory behavior was still elevated (Figure 
4E). A two-way RM ANOVA revealed a significant effect of genotype (F2,144=6.40, 
p=0.0042) and genotype-day interaction (F8,144=2.92, p=0.0047). The habituation pattern 
was less apparent for rearing behavior with no significant effects of genotype and genotype-
day interaction detected by two-way RM ANOVA on vertical counts (Figure 4F). However, 
closer examination of this data revealed a trend of decrease in vertical counts in wt (slope = 
−10.76, p= 0.06) and het (slope= −116.24, p=0.01) mice, but not in hom mutants. These data 
are further support for a habituation phenotype in β2V287L mice.
Decreased anxiety-like behaviors in β2V287L mice
nAChRs are known to be involved in pathways that control anxiety-related behaviors (32–
34). In fact some of the increased locomotor activity and lack of habituation found in these 
mice may be due to a decrease in anxiety. To directly test the effects of the V287L mutation 
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on anxiety-like behaviors we used three behavioral paradigms which test different aspects of 
anxiety; the Elevated Plus Maze (EPM), the open-field test and the light/dark test. In the 
EPM test, hom and het mutant mice displayed significantly less anxiety than wt mice (wt, n= 
19; het, n= 22; hom, n=21). Mutant animals entered the open arms of the EPM more often 
than wt mice (F2,59=12.04, p<0.0001) (Figure 5A) and spent more time in the open arms 
than wt animals (F2,59=9.80, p=0.0002), while wt mice spent more time in the closed arms 
than mutant animals (F2,59=5.27, p=0.0079)(Figure 5B). There was no overall difference in 
activity between the different genotypes in the EPM, as evidenced by a lack of difference in 
entries into the closed arms (F2,59=0.32, p=0.73), a common index of locomotor activity 
(Figure 5A). Together, these measures are consistent with overall less anxiety in β2V287L 
mutant mice in EPM tests. We also tested mice (wt: n=23; het: n=32; hom: n=19) in a 
second test of anxiety; the light/dark box. In this test het and hom did not demonstrate any 
difference from wt mice in the total transitions between the light and dark compartments (wt: 
6.87 ± 0.81; het: 7.44 ± 0.59; hom: 6.21 ± 1.21; F2,71= 0.55, p=0.58) and there was no 
difference in the time spent in the light compartment between any of the genotypes (Figure 
5C). Similarly, in an additional test of anxiety, the open-field test, no genotype differences 
were observed in the proportion of time spent by mice (wt, n=14; het, n=13; hom, n=13) in 
the center regions of the field (F2,37=0.44, p=0.65) (Figure 5D).
It is possible that the performance of mutant animals in these tests could be influenced by 
alterations in vision. However, in the Morris Water Maze test β2V287L mice did not display 
any deficits in the visible platform testing or in the hidden platform portion of the test 
(which relies on distal visual cues), suggesting that mice had no gross deficits in vision as 
well as normal spatial learning (Figure S2). Similarly average swim speeds were not 
different between genotypes (Figure S2C).
Enhanced sensitivity to nicotine-induced seizures in β2V287L mice
High doses of nicotine induce seizures in rodents by acting on nAChRs (35, 36). Prior 
studies in ADFNLE knock-in strains with mutated α4 subunits displayed higher sensitivity 
to nicotine-induced seizures and it has been suggested that increased sensitivity to nicotinic 
agonists might be related to ADNFLE (17, 22, 37, 38). To determine if β2V287L mice had an 
altered response to nicotine, we injected mice in the C57Bl/6 background with several doses 
of nicotine. Both het and hom mutant mice exhibited enhanced nicotine-induced seizure 
sensitivity compared to their wt littermates (Figure 5E). β2V287L mice also displayed 
hypersensitivity to nicotine-induced dorsiflexion (Straub tail) (22, 39) in response to 0.5–3 
mg/kg nicotine (Figure 5F). All hom mice injected with 0.25 mg/kg nicotine and all het mice 
injected with 0.5 mg/kg nicotine exhibited Straub tail, while a dose of 3 mg/kg nicotine 
elicited this response in fewer than 40% of wt mice. Susceptibility to nicotine-induced 
seizures depends on genetic background (36, 37), therefore to determine that the effects 
observed in β2V287L mice were not strain-associated, we crossed het mutants in the C57Bl/6 
background to wildtype 129/Svj mice to yield F1 offspring of C57/Bl6×129/SvJ. Het 
mutants in this mixed background also exhibited higher sensitivity to nicotine-induced 
seizures and dorsiflexion than their wt littermates (Data not shown). Thus, the β2V287L 
mutation increases an animal’s sensitivity to nicotine-induced seizures in two distinct 
genetic backgrounds.
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Discussion
Here we report the generation of the first mouse strain with a human ADNFLE knock-in 
mutation in the Chrnb2 gene. Phenotypic analysis revealed several important effects of this 
mutation on animal behavior, including alterations in activity-rest patterns, impairment in 
the development of wheel-running behavior, altered motor learning and locomotor 
habituation, and effects on anxiety-like behaviors and increased sensitivity to nicotine 
induced seizure and tail straub. These results demonstrate that the β2V287L mutation in mice 
recapitulates some of the known disruptions found in human ADNFLE patients, but in 
addition this knock-in mutation is informative of the neurobiology of high affinity β2* 
receptors.
ADNFLE
ADNFLE was the first group of familial monogenic epilepsies for which specific mutations 
were found (40). The first families described had mutations in the gene encoding the α4 
receptor subunit CHRNA4 (40, 41), and these were later followed by evidence of mutations 
in the gene encoding β2 (CHRNB2) (15, 42, 43). The importance of these linkage studies 
provided the impetus to introduce the human mutations into the mouse genome to provide 
mouse models of the human disease. Thus far, several mice harboring mutations in the α4 
subunit have been generated and described. Two strains α4 ADNFLE mice, the Chrna4S252F 
and Chrna4S248F lines, were found to have frequent spontaneous seizures associated with 
high-voltage EEG spikes (38). However, a separate mouse line created by another group 
harboring the same α4S252F did not have spontaneous seizures, but instead responded to 
low-dose nicotine injection with distinct stereotypic behaviors collectively termed dystonic 
activation complex (DAC) (37). A transgenic line (not a targeted mutation) expressing the 
same β2V287L mutant receptors, was found to have frequent spontaneous seizures (44); 
although the seizure phenotype in transgenic animals can be caused by artificial 
overexpression of β2 receptors. In the new line of knock-in mice reported here, we observed 
a very low probability of spontaneous motor seizures, which because they occurred so 
rarely, were difficult to quantify. A similar low instance of seizures were reported for α4 
knock-in lines carrying the ADNFLE mutation or hypersensitive mutations (17, 22, 37). 
Interestingly, in families with the human mutation, the penetrance of the seizure phenotype 
is also not complete, suggesting that other genetic or environmental factors play a role (15, 
45). However, consistent with the role of nicotinic receptors in modulating diverse brain 
functions, patients with ADNFLE mutations in the nicotinic receptor genes often suffer from 
multiple neurological disorders including mental retardation, memory deficits and central 
respiratory problems (46–49). Thus, mouse models provide uniquely powerful tools to 
understand the disease phenotype and improve future treatment.
Activity-rest patterns
The majority of ADNFLE seizures occur during non-REM sleep (50). However even in the 
absence of seizure activity, ADNFLE patients often endure severe sleep disruption and 
excessive daytime sleepiness (51, 52). These clinical observations suggest that ADNFLE 
mutations may affect sleep patterns and activity-rest rhythms. Furthermore, β2 mRNA levels 
have been demonstrated to be under circadian regulation with peak expression in the 
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subjective evening; suggesting that β2* receptors might be involved in regulating daily 
rhythm (53). The most prominent finding in our current study linking the knock-in mutation 
in mouse to human ADFNLE is the extensive alteration in activity-rest patterns in β2V287L 
mutant mice. These alterations were manifest in multiple ways: 1. hom mutant mice 
demonstrated an increase in the number of activity bouts, and a higher percentage of total 
activity during the light phase, suggesting more sleep disruption. 2. hom mice demonstrated 
more activity bouts with shorter average duration during the dark phase, suggesting that 
mutant mice slept more frequently during the dark cycle. 3. The activity patterns of hom 
mice during the dark cycle were significantly altered. Peak activity of wt animals occurred 
~3–5 hrs into the dark cycle then gradually declined. In contrast activity of hom mutant 
animals only slowly increased at the onset of the dark cycle but continued to increase 
throughout the dark phase. Together, these results indicate the involvement of β2* in the 
regulation of daily rhythms of activity-rest patterns. There is considerable evidence for the 
involvement of the cholinergic system in circadian rhythms. In particular, high affinity β2* 
receptors in the suprachiasmatic nucleus (SCN) have been implicated in modulating sleep-
wake patterns (54, 55). ACh levels fluctuate with the light/dark cycle in rodents, with a 
substantial increase at lights out (56) and β2 knockout mice have altered REM and non-
REM sleep patterns (14). Additionally activation of presynaptic β2-containing receptors in 
the ventral preoptic area of the hypothalamus promotes arousal by inhibiting sleep-
promoting GABAergic neurons (57). The β2V287L mutation could therefore disrupt sleep 
by disturbing the regulation of these neurons. Thus, altered activity-rest patterns in β2V287L 
knock-in mice are consistent with a role for high affinity nAChRs in sleep regulation.
Natural reward
The roles of β2* receptors in nicotine addiction has been well established, and the 
involvement of nAChRs in drug reinforcement pathways are well documented (9, 58). 
However, it is not known if β2* receptors also play a role in the natural reward system in the 
brain which involves such behaviors as consumption of food, mating behaviors, and 
exercise. We found a severe deficit in the development of voluntary wheel-running in 
β2V287L mice providing the first evidence that β2* nAChRs are also important for natural 
reward-seeking behaviors. Coincidentally, we found that matings with male hom mice did 
not produce litters as regularly as matings involving het or wt male mice. This observation 
may also be due to a decreased response to natural reward in male hom mutant mice. 
Reward-seeking behaviors, either reinforced by natural reward or by drug stimuli, depend 
critically on dopamine signaling (59). The altered function of β2V287L receptors might 
therefore have an impact on the dopaminergic system. Activation or desensitization of β2* 
nAChRs by agonists, such as nicotine or ACh, can affect DA release through several 
mechanisms. First, agonists can act directly on β2* nAChRs expressed on cell bodies of 
mid-brain dopaminergic neurons to increase their firing rate (9). Second, activation of β2* at 
the presynaptic terminals of DA neurons can lead to enhanced dopamine release in striatum 
(60). Third, activation or desensitization of β2* nAChRs on midbrain GABAergic 
interneurons can modulate the firing rate of DA neurons by regulating GABA release (61). 
Fourth, agonists can act viaβ2* nAChRs in cholinergic interneurons in striatum to regulate 
dopamine release by midbrain DA neurons (62). Thus altered activation and desensitization 
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kinetics of β2* receptors in β2V287L mice are likely to have a significant effect on reward 
pathways.
Anxiety-like behaviors
Nicotine has complex effects on anxiety. Previous studies have shown that nicotine can be 
anxiolytic and anxiogenic, depending on multiple factors including the behavioral paradigm, 
the nicotine dose, and the animal’s gender (34). Anxiolytic and anxiogenic actions of 
nicotine may be mediated by a specific subunit configuration of the nAChRs. Knockout 
mice lacking β4 or β3 subunits demonstrated reduced anxiety-like behaviors on the EPM 
(33, 63). In contrast, increased anxiety is observed by ablation of α4 (64), or in a knock-in 
mouse with a hypersensitive α4 mutation (65). Despite its widespread expression and 
involvement in several important neuronal processes the role of the β2 subunit in anxiety-
related behaviors has not been conclusively demonstrated. A number of agonists that bind to 
the α4β2* nAChRs are known to have effects on anxiety (66). However, β2−/− mice did not 
have any alteration in the EPM test (67). In our study we found that the β2V287L mutation 
has a gene-dose dependant anxiolytic effect in the EPM. This observation provides the first 
strong evidence for the involvement of β2* nAChRs in modulating some aspects of anxiety-
related behaviors. However, we performed two further anxiety tests in these mice and found 
no alterations. Anxiety is a multidimensional behavior and different tests likely evaluate 
different aspects of anxiety (68). Therefore it is likely that this divergence in findings in the 
light/dark box test and open-field test compared with the altered response in EPM test, 
suggests that the cholinergic system might be particularly important in regulating certain 
modes of anxiety.
Motor coordination, motor learning, locomotor activity and habituation
Nicotine administration affects motor skills in humans (69) and in rodent models (70). 
Ablation of either of the α7 or β2 receptor subunits individually does not have any effect on 
motor learning in mice. However, in double mutant α7 and β2 knockout mice, motor 
coordination and learning are enhanced (71). β2V287L hom mutant mice performed 
significantly better than the wt and het mice on the rotarod test further supporting a role of 
these receptors in motor learning.
One major function of nAChRs in the brain is to modulate motor activity through the 
dopaminergic system. Alterations in motor activity after nicotine exposure have been 
described in humans. Several nAChR mutant mice display altered locomotor activity and 
locomotor habituation in the open-field test (10, 72). β2−/− mice have a striking 
hyperactivity in the open-field test, presumably caused by an imbalance in DA 
neurotransmission (10). We found that β2V287L mutant mice were more active in the open-
field test; however activity changes were more nuanced than those reported in β2−/− mice. 
Increased activity in β2V287L mice was most evident during the last several hours of the dark 
phase in a normal light/dark cycle (Figure 4A), suggesting that this change in activity was 
related to the activity-rest pattern rather than the generalized hyperactivity seen in β2−/− 
mice.
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We also found that the V287L mutation had larger effects on locomotor habituation than on 
the initial exploratory activity. During the first trial of the open-field test, hom mice did not 
perform differently than het and wt littermates in the distance traveled. However, V287L 
hom mutant mice demonstrated a decreased habituation response both within the same test 
session (intra-session) and across multiple sessions (inter-session). Overall, these results 
provide additional evidence that β2* receptors have important roles in the habituation 
response of mice to a novel environment. This is consistent with previous findings that 
open-field habituation learning can be improved by nicotine and attenuated by the nAChR 
antagonists mecamylamine, which specifically blocks β2* nAChRs (73). Interestingly, 
defective habituation has been associated with Attention Deficit Hyperactivity Disorder 
(ADHD), and agonists of nAChRs can produce significant improvements in adults with 
ADHD (74, 75).
In summary, β2V287L knock-in mice provide a unique model to examine the roles of β2* 
nAChRs in vivo. The β2V287L mutation caused several behavioral alterations related both 
to the ADNFLE phenotype and to more general processes involving β2* receptors. The 
development of these mice also suggests that ADNFLE mutations may produce more 
complex biological disturbances than the manifestation of seizures. Therefore, 
understanding these complex behavioral consequences of ADNFLE mutations in the 
nicotinic receptor genes will provide better insight into the diagnosis and treatment of 
ADNFLE.
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Figure 1. Activity profiles of β2V287L mice are altered
(Ai-iii) Representative actograms of a wt, het and hom mutant mice. Observations were 
made during a 12-h light:12-h dark (LD) cycle for ~40 days. 24-h patterns of wheel-running 
activity recorded over the last 10 days of the test were analyzed for all three genotypes (n = 
10 for each group). (Bi-iii) Normalized activity profiles of wt, het and hom animals for 24 
hour LD cycle (n = 10 for each group).
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Figure 2. Disruption of activity-rest rhythm by the V287L mutation
(A) Number of activity bouts during the light phase and dark phase and (B) the average 
duration of activity bouts during each phase. (C) Average wheel turns per day for each 
genotype (D) Number of wheel turns during the dark cycle and (E) fraction of wheel turns 
during light phase. Data are presented as the mean ± SEM. *p<0.05,***p<0.001; Tukey’s 
multiple-comparison test.
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Figure 3. Deficits in development of voluntary wheel-running, but enhanced performance in 
motor coordination of β2V287L mutant mice
(A) Time-course of voluntary wheel running. Mice had free access to running wheels for 37 
days. Average daily wheel turns increased in wt and het mice over the test period. Hom mice 
showed little proclivity towards increased running behaviors (n = 10 mice for each 
genotype). (B) Performance on an accelerating rotarod task. Mice (wt, n= 23; het, n= 25; 
hom, n=19) were evaluated on the rotarod test three times a day for 3 consecutive days. 
Latency to fall of the rotating rotarod was measured on each day. Data are presented as the 
mean ± SEM of the daily averages. *p<0.05, **p < 0.01; Tukey’s multiple-comparison test. 
(C) Comparison of body weights of female (♀) and male (♂) mice (10–30 week animals).
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Figure 4. β2V287L mice demonstrate increased locomotor activity and decreased habituation
(A) Time series (28 hrs) of distance traveled during a single session open-field test. Animals 
(wt, n=14; het, n=15; hom, n =13) were introduced to open-field test chambers at 09:00 h on 
day1 with lights on. Lights were switched off at 12:00 h day 1, switched on at 0:00 h day 2 
and off at 12:00 h day 2. Experiments were stopped at 13:00 h day 2. (B) Total distance 
traveled during a full light/dark cycle (12:00 h day 1 to 12:00 h day 2). *p<0.05; Tukey’s 
multiple-comparison test. (C), Time series and (D) total distance traveled for the initial 1.5 
hour. The effect of genotype was not significant by Tukey’s multiple comparison test. 
However, a significant difference between wt and hom was detected by t-test. *p<0.05, t-
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test. (E&F) Open-field inter-session habituation test. Animals (wt, n=14; het, n=13; hom, n 
=12) were tested for 30 minutes each day over 5 consecutive days. Intersession-habituation 
was evaluated by horizontal distance traveled (E) and rearing assessed by vertical counts (F) 
across the testing sessions.
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Figure 5. Effects of V287L mutation on anxiety-related behaviors and response to nicotine
(A) Elevated-plus maze test (wt, n= 19; het, n= 22; hom, n=21). Number of entries into the 
open arms and closed arm, and (B) time spent in each arm *p<0.05, ***p<0.001; Tukey’s 
multiple-comparison test. (C) Light/dark box test (wt, n= 23; het, n=32; hom n=19). 
Percentage of total time spent in light compartment. Effect of genotype was not significant 
by Tukey’s multiple-comparison test. (D) Open-field tests (wt, n=14; het, n=13; hom, n=13). 
Total time spent in the center square. Effect of genotype was not significant by Tukey’s 
multiple-comparison test. Data are presented as the mean ± SEM. (E) Susceptibility to 
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nicotine induced seizures is reduced in β2V287L mice. Seizure severity is plotted against 
nicotine dose. (F) Quantification of straub tail in response to I/P injection of nicotine.
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